Zhaozhao Chen

ORCID: 0000-0002-2188-1367 · 1 paper in corpus
nonrandomized-trial 2020
Clinical pharmacology in drug development ·doi:10.1002/cpdd.851

Vilaprisan is a novel selective progesterone receptor modulator for the long-term treatment of uterine fibroids and endometriosis. This study investigated the pharmacokinetics, safety, and tolerability of vilaprisan in healthy Chinese postm…